{"disease":{"id":"niemann-pick-disease-type-c","name":"Niemann-Pick disease, type C","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":2},"drugs":{"marketed":[{"drug_id":"arimoclomol","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miplyffa","generic_name":"ARIMOCLOMOL","company_name":"Zevra Denmark","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Miplyffa works by activating heat shock proteins to help protect cells from damage."},{"drug_id":"levacetylleucine","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aqneursa","generic_name":"LEVACETYLLEUCINE","company_name":"Intrabio","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Aqneursa works by modifying the activity of a specific enzyme involved in the breakdown of fatty substances in the body."},{"drug_id":"miglustat","indication_name":"Niemann-Pick disease, type C","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zavesca","generic_name":"MIGLUSTAT","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Lysosomal alpha-glucosidase","drug_class":"Glucosylceramide Synthase Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Zavesca works by inhibiting the enzyme glucosylceramide synthase, which is involved in the production of a toxic lipid that accumulates in cells of patients with certain lysosomal storage disorders."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05368038","title":"ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Albert Einstein College of Medicine","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT00344331","title":"Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT05588167","title":"Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT05642221","title":"Functional Near-Infrared Spectroscopy (fNIRS) Combined With Diffuse Correlation Spectroscopy (DCS) in Neurocognitive Disease as Compared to Healthy Neurotypical Controls","phase":"","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT04958642","title":"Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Mandos LLC","has_results":true},{"nct_id":"NCT02612129","title":"Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"ZevraDenmark","has_results":true},{"nct_id":"NCT03759639","title":"N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"IntraBio Inc","has_results":true},{"nct_id":"NCT03201627","title":"Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03910621","title":"Safety and Efficacy of Miglustat in Chinese NPC Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Actelion","has_results":false},{"nct_id":"NCT02939547","title":"Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Cyclo Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02912793","title":"Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Cyclo Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03471143","title":"Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03879655","title":"Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Mandos LLC","has_results":true},{"nct_id":"NCT03887533","title":"Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":true},{"nct_id":"NCT04189601","title":"Complement Activation in the Lysosomal Storage Disorders","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Melbourne Health","has_results":false},{"nct_id":"NCT01306604","title":"Biomarker for Niemann Pick Type C Disease (BioNPC)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT04316637","title":"Early Access Program With Arimoclomol in US Patients With NPC","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"ZevraDenmark","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}